AI Optics

AI Optics builds handheld retinal cameras paired with AI screening software for point of care eye examinations. The company's stated mission is to screen everyone, everywhere, by moving retinal disease detection out of the specialist's office and into the settings where patients already are. Its Sentinel Camera captures digital images of the retina with proprietary optics in a device small enough to hold in one hand, and its software is designed to flag diabetic retinopathy, age related macular degeneration and glaucoma. It is aimed at primary care, including health systems, private practices and home health; optometry practices; retail health clinics; and long term care facilities that want to add retinal screening without referring every patient to an ophthalmologist. The Sentinel Camera holds FDA clearance and is ready for clinical use. The Sentinel Pro, which combines the camera with on device AI screening, is investigational, has not been cleared by the FDA and is limited to research use. Pricing is not published. The company invites practices to schedule a demo or request information through its contact forms. Buyers should note the regulatory split: only the imaging hardware is cleared today, and the AI diagnostic component remains in the investigational stage.